BDBM62524 2-[2-(2-Methyl-2,3-dihydro-indol-1-yl)-2-oxo-ethylsulfanyl]-nicotinic acid::2-[2-(2-methyl-2,3-dihydroindol-1-yl)-2-oxidanylidene-ethyl]sulfanylpyridine-3-carboxylic acid::2-[2-(2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl]sulfanylpyridine-3-carboxylic acid::2-[[2-(2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl]thio]-3-pyridinecarboxylic acid::2-[[2-keto-2-(2-methylindolin-1-yl)ethyl]thio]nicotinic acid::MLS000035777::SMR000003418::cid_644588

SMILES O=C(c1cnc2c(c1)OCCN2c1ccn2c(=O)n(Cc3ccncc3)nc2c1)N1CCCCC1

InChI Key InChIKey=FVJCQMLQKRCOGS-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62524   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62524BDBM62524(US12577217, Example 1-34)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent